Gossamer Bio
Kelly Dawson (Wilson) is an accomplished professional with extensive experience in technical operations and clinical supply chain management. Currently serving as Vice President of Technical Operations at Gossamer Bio since April 2018, Kelly has also held various leadership roles including Executive Director of CMC Program Management and Clinical Supply Chain. In addition to a strategic advisor position at Atreo.io, Kelly has provided independent consulting services focused on medical device R&D and pharmaceutical clinical supply chains since 2009. Prior experience includes significant roles at Receptos, Stryker Biotech, Celera Genomics, and Anteon. Kelly holds both a B.S. and an M.S. in Engineering Mechanics with a focus on Biomechanics from Virginia Tech.
This person is not in the org chart
This person is not in any teams
Gossamer Bio
1 followers
Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.